Implantation of Spheramine® in advanced Parkinson's Disease (PD)

Frontiers in Bioscience

Volumn 9, Issue , 2004, Pages 592-602

  Bakay, Roy A E ^a,e   Raiser, Cathy D ^b   Stover, Natividad P ^b   Subramanian, Thyagarajan ^c   Cornfeldt, Michael L ^d   Schweikert, Alfred W ^d   Allen, Richard C ^d   Watts, Ray ^b  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d Titan Pharmaceuticals Inc   (United States)

^e Rush Presbyt St Luke's Hospital ^*  (United States)

Author keywords

Brain; Central nervous system; Clinical Trials; CNS; Nerve; Neural Transplantation; Neuron; Retinal Pigment Epithelial Cells

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; MALE; MICROCARRIER CULTURE; PARKINSON DISEASE; PIGMENT EPITHELIUM; SAFETY; SPHERAMINE; STEREOTAXIC SURGERY; CELL TRANSPLANTATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HOSPITALIZATION; METHODOLOGY; MIDDLE AGED; PILOT STUDY; TRANSPLANTATION; TREATMENT OUTCOME;

MICROSPHERE;

CELL TRANSPLANTATION; FEMALE; HUMANS; MALE; MICROSPHERES; MIDDLE AGED; PARKINSON DISEASE; PIGMENT EPITHELIUM OF EYE; PILOT PROJECTS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 2542478946     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/1217     Document Type: Article

References (67)

1. Hornykiewicz, O. & Kish, S.J. Biochemical pathophysiology of Parkinson's disease. Adv Neurol 45, 19-34 (1986)
2. Wichmann, T., DeLong, M.R. & Vitek, J.L. Pathophysiological considerations in basal ganglia surgery: role of the basal ganglia in hypokinetic and hyperkinetic movement disorders. Prog Neurol Surg, 31-57 (2000)
3. Jankovic, J. & Marsden, C.D. Therapeutic strategies in Parkinson's disease, 191-220 (Williams & Williams, Baltimore, 1998)
4. Chase, T.N., Engber, T.M. & Mouradian, M.M. Palliative and prophylactic benefits of continuously administered dopaminomimetics in Parkinson's disease. Neurology 44, S15-8 (1994)
5. Marsden, C.D. Problems with long-term levodopa therapy for Parkinson's disease. Clin Neuropharmacol 17 Suppl 2, S32-44 (1994)
6. Chase, T.N., Juncos, J., Serrati, C., Fabbrini, G. & Bruno, G. Fluctuation in response to chronic levodopa therapy: pathogenetic and therapeutic considerations. Adv Neurol 45, 477-80 (1987)
7. Fabbrini, G., Juncos, J., Mouradian, M.M., Serrati, C. & Chase, T.N. Levodopa pharmacokinetic mechanisms and motor fluctuations in Parkinson's disease. Ann Neurol 21, 370-6 (1987)
8. Backlund, E.O., Granberg, P.O., Hamberger, B., Knutsson, E., Martensson, A., Sedvall, G., Seiger, A. & Olson, L. Transplantation of adrenal medullary tissue to striatum in parkinsonism. First clinical trials. J Neurosurg 62, 169-73 (1985)
9. Freed, C.R., Breeze, R.E., Rosenberg, N.L., Schneck, S.A., Kriek, E., Qi, J.X., Lone, T., Zhang, Y.B., Snyder, J.A. & Wells, T.H. Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease. N Engl J Med 327, 1549-55 (1992)
10. Hauser, R.A., Freeman, T.B., Snow, B.J., Nauert, M., Gauger, L., Kordower, J.H. & Olanow, C.W. Long-term evaluation of bilateral fetal nigral transplantation in Parkinson disease. Arch Neurol 56, 179-87 (1999)
11. Lindvall, O. Update on fetal transplantation: the Swedish experience. Mov Disord 13 Suppl 1, 83-7 (1998)
12. Widner, H., Tetrud, J., Rehncrona, S., Snow, B., Brundin, P., Gustavii, B., Bjorklund, A., Lindvall, O. & Langston, J.W. Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) N Engl J Med 327, 1556-63 (1992)
13. Burris, J.F. Placebo surgery in trials of therapy for Parkinson's disease. N Engl J Med 342, 353; author reply 354-5 (2000)
14. Freed, C.R., Breeze, R.E. & Fahn, S. Placebo surgery in trials of therapy for Parkinson's disease. N Engl J Med 342, 353-4; author reply 354-5 (2000)
15. Freeman, T.B., Vawter, D.E., Leaverton, P.E., Godbold, J.H., Hauser, R.A., Goetz, G.G. & Olanow, C.W. Use of placebo surgery in controlled trials of a cellular-based therapy for Parkinson's disease. N Engl J Med 341, 988-92 (1999)
16. Horisberger, J.D. Placebo surgery in trials of therapy for Parkinson's disease. N Engl J Med 342, 354-5 (2000)
17. Slattery, J. Placebo surgery in trials of therapy for Parkinson's disease. N Engl J Med 342, 354; author reply 355 (2000)
18. Weiner, W.J. Placebo surgery in trials of therapy for Parkinson's disease. N Engl J Med 342, 353; author reply 354-5 (2000)
19. Marmor, M.F. & Wolfensberger, T.J. The retinal pigments epithelium: function and disease., (Oxford University Press, New York, 1998)
20. Schraermeyer, U. & Heimann, K. Current understanding on the role of retinal pigment epithelium and its pigmentation. Pigment Cell Res 12, 219-36 (1999)
21. Pawelek, J.M. & Korner, A.M. The biosynthesis of mammalian melanin. Am Sci 70, 136-45 (1982)
22. Boulton, M. Melanin and the retinal pigment epithelium. in The Retinal Pigment Epithelium: Function and Disease, (ed. Marmor, M.F., Wolfensberger, T.J., eds.) 68-65 (Oxford University Press, New York, 1988)
23. Cherksey, B.D. Microcarrier preadhesion enhances long-term survival of adult cells implanted into the mammalian brain. Exp Neurol, S18 (1994)
24. Marchionini, D.M., Subramanian, T., Burnette, B., Miller, G.W., Iuvone, P.M., Potter, E.M. & Cornfeldt, M.L. Dopaminergic properties of retinal pigmented epithelial cells attached to microcarriers (RPE-M) transplanted into Parkinsonian animals. Amer Soc Neural Trans Repair Abstracts, A-05 (1999)
25. Burnside, B. & Bost-Usinger, L. The retinal pigment epithelial cytoskeleton. in The Retinal Pigment Epithelium: Function and Disease (ed. Marmor, M.F., Wolfensberger, T.J., eds.) 459-477 (Oxford University Press, New York, 1998)
26. Subramanian, T., Marchionini, D., Potter, E.M. & Cornfeldt, M.L. Striatal xenotransplantation of human retinal pigment epithelial cells attached to microcarriers in hemiparkinsonian rats ameliorates behavioral deficits without provoking a host immune response. Cell Transplant 11, 207-14 (2002)
27. Campochiaro, P.A. Growth factors in the retinal pigment epithelium and retina. in The Retinal Pigment Epithelium: Function and Disease (ed. Marmor, M.F., Wolfensberger, T.J., eds.) 459-477 (Oxford University Press, New York, 1998)
28. Tombran-Tink, J., Chader, G.G. & Johnson, L.V. PEDF: a pigment epithelium-derived factor with potent neuronal differentiative activity. Exp Eye Res 53, 411-4 (1991)
29. Jorgensen, A., Wiencke, A.K., la Cour, M., Kaestel, C.G., Madsen, H.O., Hamann, S., Lui, G.M., Scherfig, E., Prause, J.U., Svejgaard, A., Odum, N., Nissen, M.H. & Ropke, C. Human retinal pigment epithelial cell-induced apoptosis in activated T cells. Invest Ophthalmol Vis Sci 39, 1590-9 (1998)
30. Pfeffer, B. Improved methodology for cell culture of human and monkey retinal pigment epitheliaum. Prg Retina Res 10, 251-291 (1991)
31. Wenkel, H. & Streilein, J.W. Analysis of immune deviation elicited by antigens injected into the subretinal space. Invest Ophthalmol Vis Sci 39, 1823-34 (1998)
32. Wenkel, H. & Streilein, J.W. Evidence that retinal pigment epithelium functions as an immune-privileged tissue. Invest Ophthalmol Vis Sci 41, 3467-73 (2000)
33. Liversidge, J. & Forrester, J.V. Regulation of immune responses by the retinal pigment epithelium. in The Retinal Pigment Epithelium. Function and Disease, (ed. Marmor, M.F., Wolfensberger, T.J., eds.) 511-27. (Oxford University Press, New York, 1998)
34. Tanihara, H., Yoshida, M., Matsumoto, M. & Yoshimura, N. Identification of transforming growth factor-beta expressed in cultured human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 34, 413-9 (1993)
35. Holtkamp, G.M., de Vos, A.F., Kijlstra, A. & Peek, R. Expression of multiple forms of IL-1 receptor antagonist (IL-1ra) by human retinal pigment epithelial cells: identification of a new IL-1ra exon. Eur J Immunol 29, 215-24 (1999)
36. Campochiaro, P.A. Cytokine production by retinal pigmented epithelial cells. Int Rev Cytol 146, 75-82 (1993)
37. Dutt, K., Waldrep, J.C., Kaplan, H.J., Del Monte, M., Semple, E. & Verly, G. In vitro phenotypic and functional characterization of human pigment epithelial cell lines. Curr Eye Res 8, 435-40 (1989)
38. Rezai, K.A., Semnani, R.T., Patel, S.C., Ernest, J.T. & van Seventer, G.A. The immunogenic potential of human fetal retinal pigment epithelium and its relation to transplantation. Invest Ophthalmol Vis Sci 38, 2662-71 (1997)
39. Percopo, C.M., Hooks, J.J., Shinohara, T., Caspi, R. & Detrick, B. Cytokine-mediated activation of a neuronal retinal resident cell provokes antigen presentation. J Immunol 145, 4101-7 (1990)
40. Liversidge, J., Sewell, H.F., Thomson, A.W. & Forrester, J.V. Lymphokine-induced MHC class II antigen expression on cultured retinal pigment epithelial cells and the influence of cyclosporin A. Immunology 63, 313-7 (1988)
41. Tezel, T.H. & Del Priore, L.V. Reattachment to a substrate prevents apoptosis of human retinal pigment epithelium. Graefes Arch Clin Exp Ophthalmol 235, 41-7 (1997)
42. Cherksey, B.D. Method of increasing viability of cells which are administered to the brain or spinal cord. (U.S. Patent, 1997)
43. Cherksey, B.D. Method for transplanting cells into the brain and therapeutic uses therefor. (U.S. Patent, 1998)
44. Cherksey, B.D. Method for transplanting cells into the brain and therapeutic uses therefor. (U.S. Patent, 2000)
45. Borlongan, C.V., Saporta, S. & Sanberg, P.R. Intrastriatal transplantation of rat adrenal chromaffin cells seeded on microcarrier beads promote long-term functional recovery in hemiparkinsonian rats. Exp Neurol 151, 203-14 (1998)
46. Cherksey, B.D., Sapirstein, V.S. & Geraci, A.L. Adrenal chromaffin cells on microcarriers exhibit enhanced long-term functional effects when implanted into the mammalian brain. Neuroscience 75, 657-64 (1996)
47. Saporta, S., Borlongan, C., Moore, J., Mejia-Millan, E., Jones, S.L., Bonness, P., Randall, T.S., Allen, R.C., Freeman, T.B. & Sanberg, P.R. Microcarrier enhanced survival of human and rat fetal ventral mesencephalon cells implanted in the rat striatum. Cell Transplant 6, 579-84 (1997)
48. Potter, B.M., Kidwell, W. & Cornfeldt, M. Functional effects of intrastriatal hRPE grafts in hemiparkinsonian rats is enhanced by adhering to microcarriers. in Soc for Neurosci Abstracts (27th Annual Meeting: 778.10, 1997)
49. Subramanian, T., Bakay, R.A.E. & Cornfeldt, M.E., et al. Blinded placebo-controlled trial to assess the effects of striatal transplantation of human retinal pigmented epithelial cells attached to microcarriers (hRPE-M) in parkinsonian monkeys. Parkinsonism Rel Dis 5, S111 (1999)
50. Watts, R.L., Raiser, C.D., Stover, N.P., Cornfeldt, M.L., Schweikert, A.W., Allen, R.C., Subramanian, T., Doudet, D., Honey, C.R. & Bakay, R.A.E. Stereotaxic intrastriatal implantation of human retinal pigment epithelial (hRPE) cells attached to gelatin microcarriers: a potential new cell therapy for Parkinson's disease. J Neural Transm. 65 (Suppl.), 215-227 (2003)
51. Doudet, D., Honey, C., Schweikert, A.W. & Cornfeldt, M.L. PET imaging of implante human retinal pigment epithelial (hRPE) cells on gelatin microcarriers (Spheramine) in the MPTP-induced primate model of Parkinson's disease. in Abs. Internat Neural Transpl Repair Meeting (Denver, CO, 2002)
52. Watts, R.L., Raiser, C.D., Stover, N.P., Cornfeldt, M.L., Schweikert, A.W., Subramanian, T. & Bakay, R.A. Stereotaxic intrastriatal implantation of retinal pigment epithelial cells attached to microcarriers in advanced parkinson disease (PD) patients: a pilot study. Neurology 56 (Suppl. 3), P04.102 (2001)
53. Watts, R.L., Raiser, C.D., Stover, N.P., Cornfeldt, M.L., Schweikert, A.W., Allen, R.C., Subramanian, T. & Bakay, R.A. Stereotaxic intrastriatal implantation of retinal pigment epithelial cells attached to microcarriers in advanced Parkinson's disease (PD) patients: a pilot study in six patients. Parkinsonism Rel Dis 7(Suppl.), S87, P-TU-305 (2001)
54. Watts, R.L., Freeman, T.B., Hauser, R.A., Bakay, R.A., Ellias, S.A., Stoessl, A.J., Eidelberg, D. & Fink, J.S. A double-blind, randomized, controlled, multicenter clinical trial of the safety and efficacy of stereotaxic intrastriatal implantation of fetal porcine ventral mesencephalic tissue (Neurocell-PD™) versus imitation surgery in patients with Parkinson's disease (PD) Parkinsonism Rel Dis 7 (Suppl.), S87, P-TU-304 (2001)
55. Langston, J.W., Widner, H., Goetz, C.G., Brooks, D., Fahn, S., Freeman, T. & Watts, R. Core assessment program for intracerebral transplantations (CAPIT) Mov Disord 7, 2-13 (1992)
56. Reich, C.A., Hudgins, P.A., Sheppard, S.K., Starr, P.A. & Bakay, R.A.E. A High-Resolution Fast Spin-Echo Inversion-Recovery Sequence for Pre-Operative Localization of the Internal Globus Pallidus. Am J Neuroradiol 21, 928-31 (1997)
57. Fisher, L.D. & Bell, G.V. Biostatistics: a methodology for the health sciences, (Wiley, New York, 1993)
58. Hallett, M. & Litvan, I. Evaluation of surgery for Parkinson's disease: a report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. The Task Force on Surgery for Parkinson's Disease. Neurology 53, 1910-1921 (1999)
59. Fahn, S., Greene, P.E., Tsai, W.Y., Eidelberg, D., Winfield, H. & Dillon, S. Double-blind controlled trial of human embryonic dopaminergic tissue transplants in advanced parkinson's disease; clinical outcomes. Neurology (5), A405 (1999)
60. Fahn, S. Double-blind controlled trial of embryonic dopaminergic tissue transplants in advanced parkinson's disease. in 6th International Congress of Parkinson's Disease and Movement Disorders (Barcelona, Spain, 2000)
61. Freed, C.R., Greene, P.E., Breeze, R.E., Tsai, W.Y., DuMouchel, W., Kao, R., Dillon, S., Winfield, H., Culver, S., Trojanowski, J.Q., Eidelberg, D. & Fahn, S. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med 344, 710-9 (2001)
62. Bakay, R.A.E. Is transplantation to treat Parkinson's disease dead? Neurosurgery 49, 576-80 (2001)
63. Fabbrini, G., Mouradian, M.M., Juncos, J.L., Schlegel, J., Mohr, E. & Chase, T.N. Motor fluctuations in Parkinson's disease: central pathophysiological mechanisms, Part I. Ann Neurol 24, 366-71 (1988)
64. Colosimo, C., Merello, M., Hughes, A.J., Sieradzan, K. & Lees, A.J. Motor response to acute dopaminergic challenge with apomorphine and levodopa in Parkinson's disease: implications for the pathogenesis of the on-off phenomenon. J Neurol Neurosurg Psychiatry 61, 634-7 (1996)
65. Leenders, K.L., Poewe, W.H. & Palmer, A.J. Inhibition of (18F) flurodopa uptake into human brain by amino acids demonstrated by positron emission tomography. Ann Neurol 20, 258-262 (1986)
66. Obeso, J.A., Rodriguez-Oroz, M.C., Rodriguez, M., DeLong, M.R. & Olanow, C.W. Pathophysiology of levodopa-induced dyskinesias in Parkinson's disease: problems with the current model. Ann Neurol 47(4 Suppl 1), S22-32; discussion S32-4 (2000)
67. Hornykiewicz, O. Dopamine and Parkinson's disease. A personal view of the past, the present, and the future. Adv Neurol 86, 1-11 (2001)